Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II

Oncogene volume 20, pages 951–961 (2001)Cite this article

Abstract

The Crk II adaptor protein encodes an SH2/SH3-domain containing adaptor protein with an SH2–SH3–SH3 domain structure that transmits signals from tyrosine kinases. The two SH3 domains are separated by a 54 amino acid linker region, whose length is highly conserved in xenopus, chicken, and mamalian Crk II proteins. To gain a better understanding into the role of the C-terminal region of Crk, we generated a series of C-terminal SH3 domain and SH3 linker mutants and examined their role in tyrosine kinase pathways. Expression of point mutations in the C-terminal SH3 domain (W276K Crk), at the tyrosine phosphorylation site (Y222F Crk II), or truncation of the entire C-terminus (Crk I or Crk Δ242), all increased c-Abl binding to the N-terminal SH3 domain of Crk and, where relevant, increased Tyr222 phosphorylation. Deletion analysis of c-Crk II also revealed the presence of a C-terminal segment important for trans-activation of FAK. Such mutants, Crk Δ255 or Crk Δ242 Extended Linker (Crk Δ242[EL]), characterized by a disruption in the SH3 linker/C-terminal SH3 boundary, induced robust hyperphosphorylation of focal adhesion kinase (FAK) on Tyr397, hyperphosphorylation of focal adhesion proteins p130cas and paxillin and increased focal adhesion formation in NIH3T3 cells. The effects of Crk Δ242[EL] could be abrogated by co-expression of dominant negative c-Src or the protein tyrosine phosphatase PTP–PEST, but not by dominant negative Abl. Our results suggest that the C-terminal region of Crk contains negative regulatory elements important for both Abl and FAK dependent signal pathways, and offers a paradigm for an autoinhibitory region in the SH3 linker/C-terminal SH3 domain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Altun-Gultekin ZF, Chandriani S, Bougeret C, Ishizaki T, Narumiya S, de Graaf P, Van Bergen en Henegouwen P, Hanafusa H, Wagner JA and Birge RB. . 1998 Mol. Cell. Biol. 18: 3044–3058.

  • Angers-Loustau A, Cote JF, Charest A, Dowbenko D, Spencer S, Lasky LA and Tremblay ML. . 1999 J. Cell. Biol. 144: 1019–1031.

  • Barila D and Superti-Furga G. . 1998 Nat. Genet. 18: 280–282.

  • Birge RB, Fajardo JE, Reichman C, Shoelson SE, Songyang Z, Cantley LC and Hanafusa H. . 1993 Mol. Cell. Biol. 13: 4648–4656.

  • Birge RB, Knudsen BS, Besser D and Hanafusa H. . 1996 Genes Cells 1: 595–613.

  • Cheresh DA, Leng J and Klemke RL. . 1999 J. Cell. Biol. 146: 1107–1116.

  • Cot JF, Turner CE and Tremblay ML. . 1999 J. Biol. Chem. 274: 20550–20560.

  • Cote JF, Charest A, Wagner J and Tremblay ML. . 1998 Biochemistry 37: 13128–13137.

  • Dolfi F, Garcia-Guzman M, Ojaniemi M, Nakamura H, Matsuda M and Vuori K. . 1998 Proc. Natl. Acad. Sci. USA 95: 15394–15399.

  • Escalante M, Courtney J, Chin WG, Teng KK, Kim JI, Fajardo JE, Mayer BJ, Hempstead BL and Birge RB. . 2000 J. Biol. Chem. 275: 24787–24797.

  • Feller SM, Knudsen B and Hanafusa H. . 1994 EMBO J. 13: 2341–2351.

  • Feller SM, Posern G, Voss J, Kardinal C, Sakkab D, Zheng J and Knudsen BS. . 1998 J. Cell. Physiol. 177: 535–552.

  • Galletta BJ, Niu XP, Erickson MR and Abmayr SM. . 1999 Gene 228: 243–252.

  • Garton AJ, Burnham MR, Bouton AH and Tonks NK. . 1997 Oncogene 15: 877–885.

  • Garton AJ, Flint AJ and Tonks NK. . 1996 Mol. Cell. Biol. 16: 6408–6418.

  • Garton AJ and Tonks NK. . 1999 J. Biol. Chem. 274: 3811–3818.

  • Giancotti FG and Ruoslahti E. . 1999 Science 285: 1028–1032.

  • Hasegawa H, Kiyokawa E, Tanaka S, Nagashima K, Gotoh N, Shibuya M, Kurata T and Matsuda M. . 1996 Mol. Cell. Biol. 16: 1770–1776.

  • Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M and Matsuda M. . 1998 J. Biol. Chem. 273: 17186–17191.

  • Hildebrand JD, Schaller MD and Parsons JT. . 1995 Mol. Biol. Cell. 6: 637–647.

  • Kiyokawa E, Hashimoto Y, Kobayashi S, Sugimura H, Kurata T and Matsuda M. . 1998a Genes Dev. 12: 3331–3336.

  • Kiyokawa E, Hashimoto Y, Kurata T, Sugimura H and Matsuda M. . 1998b J. Biol. Chem. 273: 24479–24484.

  • Kizaka-Kondoh S, Matsuda M and Okayama H. . 1996 Proc. Natl. Acad. Sci. USA 93: 12177–12182.

  • Knudsen BS, Feller SM and Hanafusa H. . 1994 J. Biol. Chem. 269: 32781–32787.

  • Ling P, Yao Z, Meyer CF, Wang XS, Oehrl W, Feller SM and Tan TH. . 1999 Mol. Cell. Biol. 19: 1359–1368.

  • Matsuda M, Hashimoto Y, Muroya K, Hasegawa H, Kurata T, Tanaka S, Nakamura S and Hattori S. . 1994 Mol. Cell. Biol. 14: 5495–5500.

  • Matsuda M and Kurata T. . 1996 Cell Signal 8: 335–340.

  • Mayer BJ, Hamaguchi M and Hanafusa H. . 1988 Cold Spring Harb. Symp. Quant. Biol. 53: 907–914.

  • Mayer BJ, Hirai H and Sakai R. . 1995 Curr. Biol. 5: 296–305.

  • Mochizuki N, Ohba Y, Kobayashi S, Otsuka N, Graybiel AM, Tanaka S and Matsuda M. . 2000 J. Biol. Chem. 275: 12667–12671.

  • Nojima Y, Morino N, Mimura T, Hamasaki K, Furuya H, Sakai R, Sato T, Tachibana K, Morimoto C, Yazaki Y, et al. 1995 J. Biol. Chem. 270: 15398–15402.

  • Ogawa S, Toyoshima H, Kozutsumi H, Hagiwara K, Sakai R, Tanaka T, Hirano N, Mano H, Yazaki Y and Hirai H. . 1994 Oncogene 9: 1669–1678.

  • Oktay M, Wary KK, Dans M, Birge RB and Giancotti FG. . 1999 J. Cell. Biol. 145: 1461–1469.

  • Polte TR and Hanks SK. . 1995 Proc. Natl. Acad. Sci. USA 92: 10678–10682.

  • Reddien PW and Horvitz HR. . 2000 Nat. Cell. Biol. 2: 131–136.

  • Reichman CT, Mayer BJ, Keshav S and Hanafusa H. . 1992 Cell Growth Differ. 3: 451–460.

  • Richardson A, Malik RK, Hildebrand JD and Parsons JT. . 1997 Mol. Cell. Biol. 17: 6906–6914.

  • Rosen MK, Yamazaki T, Gish GD, Kay CM, Pawson T and Kay LE. . 1995 Nature 374: 477–479.

  • Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y and Hirai H. . 1994 EMBO J. 13: 3748–3756.

  • Schlaepfer DD, Broome MA and Hunter T. . 1997 Mol. Cell. Biol. 17: 1702–1713.

  • Schlaepfer DD, Hanks SK, Hunter T and van der Geer P. . 1994 Nature 372: 786–791.

  • Schlaepfer DD and Hunter T. . 1997 J. Biol. Chem. 272: 13189–13195.

  • Senechal K, Heaney C, Druker B and Sawyers CL. . 1998 Mol. Cell. Biol. 18: 5082–5090.

  • Shen Y, Schneider G, Cloutier JF, Veillette A and Schaller MD. . 1998 J. Biol. Chem. 273: 6474–6481.

  • Sicheri F, Moarefi I and Kuriyan J. . 1997 Nature 385: 602–609.

  • Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, et al. 1994 Mol. Cell. Biol. 14: 2777–2785.

  • Tamura M, Gu J, Danen EH, Takino T, Miyamoto S and Yamada KM. . 1999 J. Biol. Chem. 274: 20693–20703.

  • Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada KM. . 1998 Science 280: 1614–1617.

  • Tanaka S and Hanafusa H. . 1998 J. Biol. Chem. 273: 1281–1284.

  • Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M, Matuoka K, Takenawa T, Kurata T, Nagashima K, et al. 1994 Proc. Natl. Acad. Sci. USA 91: 3443–3447.

  • ten Hoeve J, Morris C, Heisterkamp N and Groffen J. . 1993 Oncogene 8: 2469–2474.

  • Vuori K and Ruoslahti E. . 1995 J. Biol. Chem. 270: 22259–22262.

  • Wu X, Knudsen B, Feller SM, Zheng J, Sali A, Cowburn D, Hanafusa H and Kuriyan J. . 1995 Structure 3: 215–226.

Download references

Acknowledgements

We would like to thank Tomoyuki Shishido and Hidesaburo Hanafusa for discussing unpublished results, and Jong-Il Kim for helpful discussions. We also thank Paul Kaloudis for his assistance in the digital imaging of the immunofluoresence studies and Jason Ptacek for help in the preparation of figures. This work was supported by Public Health Service Awards to RB Birge (RO1 GM55760) and from a Muscular Dystrophy Association (MDA) grant.

Author information

Author notes

  1. Agnes Zvara

    Present address: Biochip Laboratory, BRC, Hungary Academy of Sciences, Szeded POB 521, H6701, Hungary

  2. Raymond B Birge

    Present address: Department of Biochemistry and Molecular Biology MSB-E647, UMDNJ-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103-2714, USA

  3. Agnes Zvara and J Eduardo Fajardo: A Zvara and JE Fajardo contributed equally to this work

Authors and Affiliations

  1. Laboratory of Molecular Oncology, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA

    Agnes Zvara, J Eduardo Fajardo, Marcela Escalante, Kathrin H Kirsch & Raymond B Birge

  2. Laboratory of Synthetic Protein Chemistry, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA

    Graham Cotton & Tom Muir

Authors
  1. Agnes Zvara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Eduardo Fajardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcela Escalante
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Graham Cotton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tom Muir
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kathrin H Kirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raymond B Birge
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zvara, A., Fajardo, J., Escalante, M. et al. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene 20, 951–961 (2001). https://doi.org/10.1038/sj.onc.1204173

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204173

Keywords

This article is cited by

Search

Advanced search

Quick links